Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update
The Pharma Data
NOVEMBER 4, 2020
Expanded m edical society recommendations in support of the efficacy and safety of VASCEPA : The European Society of Cardiology expanded their guidelines to recommend use of VASCEPA in treating acute coronary syndrome patients. Patients with such allergies should discontinue VASCEPA if any reactions occur. VASCEPA.
40 
Let's personalize your content